Skip to main content
Equibles

VIRTUS ADVISERS, LLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1587281 HARTFORD, CT
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$359,940
-$68,180 QoQ
Shares Held
315,737
+2.5% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#40
of 170 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

VIRTUS ADVISERS, LLC holds $9,867,527 across 13 Drug Manufacturers - Specialty & Generic names. AKBA ranks #8 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
 49,354 $2,586,149
2 RDY
Dr Reddys Laboratories Ltd
 107,110 $1,552,023
3 PAHC
Phibro Animal Health Corp
 43,092 $1,353,088
4 ANIP
Ani Pharmaceuticals Inc
 14,294 $1,183,257
5 LQDA
Liquidia Corp
 8,680 $692,055
6 AMRX
Amneal Pharmaceuticals, Inc.
 36,823 $637,406
7 NBIX
Neurocrine Biosciences Inc
 2,714 $457,417
8 AKBA
Akebia Therapeutics, Inc.
This page 		315,737 $359,940

All Filings in AKBA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,940 315,737
2026-03-31 $428,120 308,000
2022-03-31 $46,776 65,149
2021-12-31 $155,973 69,015
2021-09-30 $167,739 58,243
2021-06-30 $232,266 61,284
2021-03-31 $319,652 94,432
2020-12-31 $259,758 92,771
2020-09-30 $69,140 27,546
2020-06-30 $424,958 31,293
2020-03-31 $426,526 56,270